ERISBSEEris Lifesciences LtdMediumNeutral
Announced Wed, 20 May · 19:29 IST

as attached

Investor Communications View source PDF

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.8%1-day move
₹1489.20
prior close
₹1489.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-2.4-2.0-1.7-9.8-9.1-8.6-9.1-6.4-8.5-5.9-3.4-1.3
Up moveDown movePending
AI summary

Eris Lifesciences has notified exchanges that the audio recording and transcript of its earnings conference call held on May 20, 2026 is now available on the company website. The call covered the audited standalone and consolidated financial results for Q4 and the financial year ended March 31, 2026. This is a standard post-earnings disclosure obligation under SEBI LODR regulations, making the management discussion accessible to all shareholders.

Likely market impact

The filing itself carries no new financial information; it merely publishes the earnings call recording. Investors should listen to the call for any forward-looking commentary on margins, growth strategy, or debt management that may influence the stock.